BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30411177)

  • 1. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
    Ippolito D; Pecorelli A; Famularo S; Bernasconi D; Orsini EB; Giani A; Romano F; Talei Franzesi C; Sironi S
    Abdom Radiol (NY); 2019 Apr; 44(4):1340-1349. PubMed ID: 30411177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating liver function in a large cirrhotic cohort: Signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI.
    Ippolito D; Famularo S; Giani A; Orsini EB; Pecorelli A; Pinotti E; Gandola D; Romano F; Sironi S; Bernasconi DP; Gianotti L
    Dig Liver Dis; 2019 Oct; 51(10):1438-1445. PubMed ID: 31153787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
    Verloh N; Haimerl M; Zeman F; Schlabeck M; Barreiros A; Loss M; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
    Eur Radiol; 2014 May; 24(5):1013-9. PubMed ID: 24531844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.
    Kim HY; Choi JY; Park CH; Song MJ; Song DS; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE
    J Gastroenterol; 2013 Oct; 48(10):1180-7. PubMed ID: 23354621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI.
    Yang M; Zhang Y; Zhao W; Cheng W; Wang H; Guo S
    BMC Med Imaging; 2020 Oct; 20(1):119. PubMed ID: 33081713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
    Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
    Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR liver imaging with Gd-EOB-DTPA: The need for different delay times of the hepatobiliary phase in patients with different liver function.
    Liang M; Zhao J; Xie B; Li C; Yin X; Cheng L; Wang J; Zhang L
    Eur J Radiol; 2016 Mar; 85(3):546-52. PubMed ID: 26860666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.
    Yoneyama T; Fukukura Y; Kamimura K; Takumi K; Umanodan A; Ueno S; Nakajo M
    Eur Radiol; 2014 Apr; 24(4):857-65. PubMed ID: 24356768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla.
    Zhang W; Wang X; Miao Y; Hu C; Zhao W
    Abdom Radiol (NY); 2018 Sep; 43(9):2262-2269. PubMed ID: 29476347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
    Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
    Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
    Ding Y; Rao SX; Chen C; Li R; Zeng MS
    Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.
    Verloh N; Haimerl M; Rennert J; Müller-Wille R; Nießen C; Kirchner G; Scherer MN; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
    Eur J Radiol; 2013 Oct; 82(10):1710-5. PubMed ID: 23806531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis.
    Lee S; Choi D; Jeong WK
    J Magn Reson Imaging; 2016 Nov; 44(5):1339-1345. PubMed ID: 27197633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging.
    Higaki A; Tamada T; Sone T; Kanki A; Sato T; Tanimoto D; Higashi H; Ito K
    Magn Reson Imaging; 2012 Jun; 30(5):689-93. PubMed ID: 22459437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin-bilirubin grading system.
    Takatsu Y; Kobayashi S; Miyati T; Shiozaki T
    Eur J Radiol; 2016 Dec; 85(12):2206-2210. PubMed ID: 27842668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
    Haimerl M; Schlabeck M; Verloh N; Zeman F; Fellner C; Nickel D; Barreiros AP; Loss M; Stroszczynski C; Wiggermann P
    Eur Radiol; 2016 Apr; 26(4):1125-33. PubMed ID: 26186960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.